Bardzo tanie apteki z dostawą w całej Polsce kupic viagra i ogromny wybór pigułek.

List of publications - professor thomas grünberger md

Original articles:
Changes in hepatic tissue water content in EC-, UW-, and HTK-preserved livers tested in a pig liver transplant model R. Steininger, E. Roth, P. Holzmüller, H. Reckendorfer, M.
Sperlich, T. Gruenberger, E. Moser, F. Mühlbacher
Transplantation Proceedings 1991; 23(5): 2414
Comparison of HTK- and UW- solution for liver preservation
tested in an olt model in the pig
R. Steininger, E. Roth, P. Holzmüller, H. Reckendorfer,
T. Gruenberger, M. Sperlich, H. Burgmann, E. Moser, W. Feigl,
M. Mühlbacher
Transplant International 1992; 5: 403
The impact of donor age on graft function in living related
kidney transplantation
F. Längle, T. Sautner, T. Gruenberger, P. Götzinger,
F. Mühlbacher
Transplantation Proceedings 1992; 24(6): 2725
Die UW-Lösung in der Organkonservierung für die orthotope
Lebertransplantation
R. Steininger, F. Mühlbacher, E. Roth, T. Gruenberger, P.
Götzinger, P. Wamser, F. Längle, H. Reckendorfer, M. Sperlich
Acta Chirurgica Austriaca 1992; 24: 231-236
Impact of vesicoureteral reflux on graft survival in renal transplantation
T. Gruenberger, M. Gnant, T. Sautner, K. Höberth, R. Steininger,
J. Hofbauer, F. Mühlbacher
Transplantation Proceedings 1993; 25(1): 1058
Impact of donor criteria on postoperative graft function in
liver transplantation
Th. Gruenberger, R. Steininger, M. Mittlböck, Th. Sautner,
P.Wamser, F. Mühlbacher
Transplantation Proceedings 1993: 25(6): 3156
Value of serum soluble tumour necrosis factor concentration in the
diagnosis and prognosis of renal graft rejection
M. Keil, MK. Pec, G. Schenn, Th. Gruenberger, G. Kramer,
R. Függer, R. Steininger, F. Mühlbacher, P. Balke, F. Stockenhuber
Nephro Dial Transplant 1994; 9(7): 815-819
Andrologic status before and after liver transplantation
S. Madersbacher, Th. Gruenberger, U. Maier
J. of Urology 1994; 151(5): 1251-4
L-Arginine deficiency after liver transplantation as an effect of
arginase efflux from the graft; influence on nitric oxide metabolism
E. Roth, R. Steininger, S. Winkler, F. Längle, Th. Gruenberger,
R. Függer, F. Mühlbacher
Transplantation 1994; 57(5): 665
Transhepatic metabolism of TNF-a, IL-6 and Endotoxin in the early
hepatic reperfusion period after human liver transplantation
R. Steininger, E. Roth, R. Függer, S. Winkler, F. Längle,
Th. Gruenberger, P. Götzinger, F. Mühlbacher
Transplantation 1994, 58(2): 179-83
Influence of donor criteria on postoperative graft function
after oLTX
Th. Gruenberger, R. Steininger, Th. Sautner, M. Mittlböck,
F. Mühlbacher
Transplant International 1994; 7(Supp1): 672
Kann man einer hochselektionierten Patientinnengruppe nach
brusterhaltender Therapie wegen Mammakarzinoms die postoperative
Nachbestrahlung ersparen?
Th. Gruenberger, M. Gorlitzer, Th. Soliman, M. Rudas,
M. Mittlböck, P. Götzinger, M. Gnant, A. Reiner, B. Teleky,
W. Seitz, R. Jakesz
Acta Chirurgica Austriaca 1995; 27(5/6): 269-273
Tumor recurrence after oLTX
Th. Gruenberger, Th. Windhager, M. Gnant, M. Mittlböck,
R. Steininger, F. Herbst, F. Mühlbacher
Transplant International 1996; 9(Sup1): S151
Prediction of graft dysfunction by analysis of liver biopsies
after cold storage
Th. Gruenberger, S. Winkler, F. Garro, M. Barlan, W. Huber,
E. Roth, R. Steininger, F. Mühlbacher
Transplant International 1996; 9(Sup1): S132
The impact of liver transplantation on endocrine status in men
St. Madersbacher, G. Ludvik, Th. Stulnig, Th. Gruenberger,
U. Maier
Clinical Endocrinlogy 1996; 44: 461-466
Improvement of cardiac output and liver blood flow and reduction
of pulmonary vascular resistance by intravenous infusion of L-Arginine
during the early reperfusion period in pig liver transplantation
F. Längle, R. Steininger, E. Waldmann, Th. Gruenberger, H. Benditte,
M. Mittlböck, Th. Soliman, M. Schindl, U. Windberger, F. Mühlbacher, E.
Roth
Transplantation 1997; 63: 1225-1233
Late ureteral obstruction after kidney transplantation
U. Maier, S. Madersbacher, S. Banyai-Falger, M. Susani,
Th. Gruenberger
Transplant International 1997; 10: 65-68
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I
breast cancer patients
R. Jakesz, H. Salmonigg, M. Gnant, E. Kubista, P. Steindorfer, H.
Hausmaninger, P. Sevelda, B. Tschurtschenthaler, M. Fridrik, M. Stierer,
R. Kolb, G. Steger and the Austrian Breast Cancer Study Group
European Journal of Cancer 1998; 34/1: 66-70
It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients Th. Gruenberger, M. Gorlitzer, T. Soliman, M. Rudas, M. Mittlböck, M.
Gnant, A. Reiner, B. Teleky, Seitz, R. Jakesz
Breast Cancer Research and Treatment 1998; 50: 37-46 Liver resection and transplantation - therapeutic concepts in surgical
treatment of hepatic metastases
R. Steininger, Th. Gruenberger
Acta Chirurgica Austriaca 1998; 30: 206-210
Preservation of the liver- is it possible to extend the time of storage?
H. Pokorny, Th. Gruenberger, S. Rockenschaub, H. Puhalla, F.
Mühlbacher,
R. Steininger
Transplantation Proceedings 1999; 31/5: 2074-76
First experiences with mesh wrapping for parenchymal liver injuries in orthotopic liver transplantation (OLT) Th. Soliman, H. Pokorny, S. Rockenschaub, H. Puhalla, T. Gruenberger,
M. Schindl, F. Längle, G. Berlakovich, F. Mühlbacher, R. Steininger
Transplantation Proceedings 1999; 31(1-2): 538-9
Immunmodulated effects of glycine in LPS-treated monocytes: reduced
TNF-a production and accelerated IL-10 expression
A. Spittler, CM. Reissner, R. Oehler, A. Gornikiewicz, Th. Gruenberger,
N. Manhart, T. Brodowicz, M. Mittlboek, G. Boltz-Nitulescu, E. Roth
Randomized trial of low-dose chemotherapy added to Tamoxifen in
patients with receptor-positive and lymph node-positive breast cancer
R. Jakesz, H. Hausmaninger, K. Haider, E. Kubista, H. Salmonigg, M.
Gnant, D. Manfreda, G. Tschurtschenthaler, R. Kolb, M. Stierer, M. Fridrik,
B. Mlineritsch, P. Steindorfer, M. Mittlboeck, G. Steger, and the Austrian
Breast Cancer Study Group
Journal of Clinical Oncology 1999; 17/6: 1701-1709
Prognostic significance of mutations in the p53 gene, particularly in the
zinc-binding domains, in lymph node- and steroid receptor positive breast
cancer patients
E. Kucera, P. Speiser, M. Gnant, L. Szabo, H. Samonigg, H. Hausmaninger,
M. Mittlboeck, M. Fridrik, M. Seifert, E. Kubista, A. Reiner, R. Zeillinger, R.
Jakesz and the Austrian Breast Cancer Study Group
European Journal of Cancer 1999; 35/3: 398-405
Management of organ donation following trauma in conventional heart-beating donor and non-heart-beating donor situations H. Pokorny, H. Puhalla, CG. Krenn, T. Soliman, F. Langer,
Th. Gruenberger, B. Gollackner, M. Schindl, P. Wamser, P. Goetzinger,
T. Sautner, MF. Gnant, R. Steininger, F. Muehlbacher
Trauma Care 1999; 9/1: 30-32
Organ survival after primary dysfunction of liver grafts in clinical oLT H. Pokorny, Th. Gruenberger, T. Soliman, S. Rockenschaub, F. Längle,
R. Steininger
Transplant International, 2000;13 Suppl 1:S154-7
Parenchymal liver injuries in orthotopic liver transplantation
T. Soliman, F. Langer, H. Puhalla, H. Pokorny, Th. Gruenberger,
G.A. Berlakovich, R. Steininger and F. Mühlbacher
Transplantation 2000;69(10):2079-84
Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment
Th. Gruenberger
, JL. Jourdan, J. Zhao, J. King, DL. Morris
Archieves of Surgery 2000; 135(11): 1285-90
Reduction in recurrence risk for involved or inadequate margins with
edge cryotherapy after liver resection for colorectal metastases
Th. Gruenberger, JL. Jourdan, J. Zhao, J. King, DL. Morris
Arch Surg. 2001 Oct;136(10):1154-7
Extending the limits for curative liver resections by portal vein
embolisation
KS. Haghighi, D. Glenn, Th. Gruenberger, DL. Morris
Int Surg. 2009 Jan-Feb;94(1):43-7.
Echogenicity of liver metastases from colorectal carcinoma is an
independent prognostic factor in patients treated with regional
chemotherapy
Gruenberger T, Zhao J, King J, Chung T, Clingan PR, Morris DL
Cancer 2002 Mar 15;94(6):1753-9
Long-term follow-up of surgically treated gallbladder cancer patients
Puhalla H, Wild T, Bareck E, Pokorny H, Ploner M, Soliman T, Stremitzer S,
Depisch D, Laengle F, Gruenberger T
Eur J Surg Oncol 2002 Dec;28(8):857-63
Staged treatment of bilobar hepatic metastases from colorectal cancer
Th. Gruenberger, DL. Morris
Eur J Surg. 2002;168(8-9):516-8
Alternative regional treatment of resectable and unresectable liver
metastases
Th. Gruenberger
Eur Surg 2002,34/6, 337-40
Current strategies in the treatment of colorectal cancer liver metastases:
aspects of surgical treatment
M. Schindl, Th. Gruenberger, F. Längle
Eur Surg 2002, 34/6, 332-6
Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol:
Pilot study in patients with hepatocellular carcinoma
Morris DL, Jourdan JL, Finlay I, Gruenberger T, The MP, Pourgholami MH
Int J Oncol 2002 Oct;21(4):901-6
Resection of Hilar Cholangiocarcinomas: Pivotal Prognostic Factors and
Impact of Tumor Sclerosis
Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U,
Winkler T, Ploner M, Raderer M, Steininger R, Muhlbacher F, Laengle F
World J Surg 2003; 27/6: 680-4
Mitomycin C in combination with capacitabine or biweekly high dose
gemcitabine in patients with advanced biliary tract cancer: a randomized
phase II trial
Kornek GV, Schuell B, Laengle F, Gruenberger T, Penz M, Karall K,
Depisch D, Lang F, Scheithauer W
Ann Oncology 2004, 15, 478-83
p53 analyses in gallbladder cancer: comparison of gene analysis versus immunohistochemistry Puhalla H, Kandioler D, Ludwig C, Filipits M, Wrba F, Laengle F, Jakesz R,
Gruenberger T
Anticancer Research, 2004, 24, 1201-6
Changes in liver surgery for colorectal cancer liver metastases under
neoadjuvant treatment strategies
Th. Gruenberger, B. Schuell, H. Puhalla, E. Schwanzer, M. Bodingbauer,
F. Laengle, G. Kornek, W. Scheithauer
European Surgery 2004, 36/5; 317-21
Anforderungen der Chirurgie an die bildgebende Diagnostik
Th. Gruenberger
Radiologe 2004, 44; 1154-59
Treatment and outcome of intrahepatic cholangiocellular carcinoma
H. Puhalla, B. Schuell, H. Pokorny, GA. Kornek, W. Scheithauer, Th.
Gruenberger
Am J Surgery 2005, 189/2; 173-7
Multidetector-CT (MDCT) der Leber
W. Schima, C. Kulinna, A. Ba-Ssalamah, Th. Gruenberger
Radiologe 2005, 45/1; 15-23
45. Influence of laparoscopy on survival after surgery for gallbladder carcinoma: a matched-pair analysis
Puhalla, H., Gruenberger, T., Pokorny, H., Ploner, M., Bareck, E.,
Depisch, D., Zacherl, J., Bischof, G.
European Surgery 2004, 36/6; 350-55
Interdisciplinary management of colorectal cancer liver metastases
Th. Gruenberger, B. Gruenberger, A. Becherer, J. Kettenbach,
K. Dieckmann, W. Schima
European Surgery 2006, 38/2; 107-11
Side effects during chemotherapy predict tumour response in advanced
colorectal cancer
B. Schuell, Th. Gruenberger, G. Kornek, N. Dworan, D. Depisch, F. Lang,
B. Schneeweiss, W. ScheithauerBritsch Journal of Cancer 2005; 93, 744-48 E-Cadherin and β-Catenin expression in normal, inflamed and cancerous
gallbladder tissue
H. Puhalla, B. Herberger, A. Soleiman, M. Filipits, F. Laengle,
Th. Gruenberger, F. Wrba
Anticancer Research 2005; 25, 4249-54
Neoadjuvant therapy with Bevacizumab
Th. Gruenberger, B. Gruenberger, W. Scheithauer
Journal Clinical Oncology 2006; 24, 2592-93
HER-2/neu protein expression in colorectal cancer
B. Gruenberger, Th. Gruenberger, W. Scheithauer, C. Zielinski, F. Wrba
BMC Cancer 2006; 6: 123
Selective resection of colorectal liver metastases
D. Tamandl, B. Gruenberger, B. Herberger, S. Schoppmann, M.
Bodingbauer, M. Schindl, H. Puhalla, E. Fleischmann, W. Schima, R.
Jakesz, F. Laengle, Th. Gruenberger
Eur J Surg Oncol 2007; 33:174-82
Size of surgical margin does not influence recurrence rates after curative
liver resection for colorectal cancer liver metastases
M. Bodingbauer, D. Tamandl, K. Schmid, C. Plank, W. Schima,
Th. Gruenberger
Br J Surgery 2007; 94(9): 1133-8
Expression of p21Wafl/Cip1, p57Kip2 and HER2/neu in Patients with Gallbladder
Cancer
H Puhalla, F Wrba, D Kandioler, M Lehnert, A Huynh, T Gruenberger,
D Tamandl, M Filipits
Anticancer Research 2007; 27(3B): 1679-84
Activated mTOR is an adverse prognostic factor in patients with
biliary tract adenocarcinoma
B. Herberger, H. Puhalla, M. Lehnert, F. Wrba, S. Novak, A. Brandstetter,
Th. Gruenberger, R. Pirker, M. Filipits
Clin Cancer Research 2007; 13(16): 4795-9
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment GroupB. Nordlinger, Eur J Cancer 2007; 43(14): 2037-45 Post-treatment imaging of liver tumours
W. Schima, A. Ba-Ssalamah, A. Kurturan, M. Schindl, Th. Gruenberger
Cancer Imaging 2007; 7: S28-S36
Effects of continous remifentanil administration on intra-operative
subcutaneous tissue oxygen tension
B. Kabon, A. Kugener, Th. Gruenberger, M. Niedermayr, E. Fleischmann,
M. Freissmuth, A. Kurz
Anaesthesia 2007; 62: 1101-9
Adequate preoperative staging rarely leads to a change of intraoperative
strategy in patients undergoing surgery for colorectal cancer liver
metastases
D. Tamandl, B. Herberger, B. Gruenberger, S. Schoppmann, H. Puhalla, M.
Schindl, W. Schima, R. Jakesz, Th. Gruenberger
Surgery 2008; 143(5): 648-57
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for
patients with potentially curable metastatic colorectal cancer
B. Gruenberger, D. Tamandl, J. Schueller, W. Scheithauer, C. Zielinski,
F. Herbst, Th. Gruenberger
Journal Clinical Oncology 2008; 26(11): 1830-5
Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The
Perioperative Angiogenic Balance is Sensitive to Systemic
Thrombospondin-1 Levels
C. Brostjan, K. Gebhardt, B. Gruenberger, S. Roka, Th. Gruenberger
Clin Cancer Research 2008; 14(7): 2065-74
Patterns of Hepatotoxicity after Chemotherapy for Colorectal Cancer
Liver Metastases
S. Kandutsch, M. Klinger, S. Hacker, F. Wrba, B. Gruenberger,
Th. Gruenberger
Eur J Surg Oncol. 2008 Nov;34(11):1231-6. Epub 2008 Feb 12
Randomized study of perioperative chemotherapy with FOLFOX4 and
surgery versus surgery alone for resectable liver metastases from
colorectal cancer (EORTC Intergroup trial 40983)
B. Nordlinger, H. Sorbye, B. Glimelius, GJ. Poston, P. M. Schlag, P.
Rougier, W. Bechstein, JN. Primrose, ET. Walpole, M. Finch-Jones, D.
Jaeck, D. Mirza, RW. Parks, L. Collette, M. Praet, U. Bethe, E. Van Cutsem,
W. Scheithauer, T. Gruenberger
Lancet 2008; 371(9617): 1007-16
63. Using Bevacizumab and Cetuximab before liver surgery B. Gruenberger, Th. Gruenberger
Current colorectal cancer reports 2008; 4: 126-9
Importance of response to neoadjuvant chemotherapy in potentially
curable colorectal cancer liver metastases
B. Gruenberger, W. Scheithauer, R. Punzengruber, C. Zielinski, D.
Tamandl,
Th. Gruenberger
BMC Cancer 2008; 25/8: 120
Consensus on the medical treatment of colon cancer
G. Kornek, W. Scheithauer, R. Anghel, G. Bodoky, F. Ciardiello,
T. Ciuleanu, R. Glynne-Jones, T. Gruenberger, I. Koza, J. Ocvirk,
L. Petruzelka, G. Poston, G. Ramadori, W. Schmiegel, S. Segaert,
J. Tabernero, H. Zwierzina, C. Zielinski
Magazine of European Medical Oncology 2008; 1: 79-90
Surgery vs surgery and chemotherapy for colorectal liver metastases
B. Nordlinger, Th. Gruenberger, H. Sorbye, B. Glimelius, L. Collettte
Lancet 2008, 372 (9634): 203
Trials on preoperative chemotherapy in resectable colorectal liver
metastases need prospective evaluation of predictive factors of response
Th. Gruenberger, B. Gruenberger
J Clin Oncology 2008; 26, 3813
Urgent Need for a New Staging System in Advanced Colorectal Cancer.
GJ. Poston, J. Figueras, F. Giuliante, G. Nuzzo, AF. Sobrero, JF. Gigot,
B. Nordlinger, R. Adam, T. Gruenberger, MA. Choti, AJ. Bilchik, EJ. Van
Cutsem, JM. Chiang, MI. D'Angelica MI
Journal Clinical Oncology 2008; 26: 4828-33
Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma D. Tamandl, B. Herberger, B. Gruenberger, H. Puhalla, M. Klinger,
Th. Gruenberger
Ann Surg Oncology 2008; 15: 2787-94
HB-EGF is a paracrine growth stimulator for early tumor-prestages in
inflammation-associated hepatocarcinogenesis
S. Sagmeister, C. Drucker, A. Losert, M. Grusch, A. Daryabeigi, W.
Parzefall,
N. Rohr-Udilova, C. Bichler, B. Smedsrod, D. Kandioler,
Th. Gruenberger, F. Wrba, R. Schulte-Hermann, B. Grasl-Kraupp
J Hepatol. 2008 Dec;49(6):955-64. Epub 2008 Oct 7.
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel B. Nordlinger, E. Van Cutsem, Th. Gruenberger, B. Glimelius,
G. Poston, P. Rougier, A. Sobrero, M. Ychou on behalf of the European Colorectal Metastases Treatment GroupAnn Oncology 2009 Jun;20(6):985-92. Epub 2009 Jan 19. Bevacizumab protects against sinusoidal obstruction syndrome and does
not increase response rate in neoadjuvant XELOX/FOLFOX therapy of
colorectal cancer liver metastases
M. Klinger, S. Eipeldauer, S. Hacker, B. Herberger, D. Tamandl, M.
Dorfmeister, C. Koelblinger, B. Gruenberger, Th. Gruenberger
Eur J Surg Oncol 2009; 35: 515-20
Nitrous oxide may not increase the risk of cancer recurrence after
colorectal surgery: a follow-up of a randomized controlled trial
E. Fleischmann, C. Marschalek, K. Schlemitz, J. Dalton,
Th. Gruenberger,
F. Herbst, A. Kurz, D. Sessler
BMC Anaesthesiology 2009; 9: 1
Surgery after neoadjuvant chemotherapy for colorectal liver
metastases is safe and feasible in elderly patients
D. Tamandl, B. Gruenberger, K. Kaczirek, B. Herberger, Th.
Gruenberger
Endo-sponge assisted treatment of anastomotic leakage following
colorectal surgery
S. Riss, A. Stift, M. Meier, E. Haiden, Th. Gruenberger, M. Bergmann
Colorectal Dis. 2010 Jul;12(7 Online):e104-8. Epub 2009 Apr 13
Lymph node ratio after curative surgery for intrahepatic
cholangiocarcinoma
D. Tamandl, K. Kaczirek, B. Gruenberger, C. Koelblinger, J. Maresh, R.
Jakesz, Th. Gruenberger
Br J Surgery 2009; 96: 919-25
B. Herberger, W. Berger, H. Puhalla, K. Schmid, S. Novak, A. Brandstetter,
C. Pirker Th. Gruenberger, M. Filipits
Mol Cancer Ther. 2009 Jun;8(6):1547-56. Epub 2009 Jun 9
Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D,
De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D,
Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu
A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de
Velde C
Ann Oncol. 2009 Jun;20 Suppl 7:vii1-vii6
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization
in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION
V Study
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M,
Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger
T
, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C,
Chevallier P, Lencioni R; On Behalf of the PRECISION V Investigators.
Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52. Epub 2009 Nov 12.
The EGF 61A/G polymorphism - a predictive marker for recurrence of liver
metastases from colorectal cancer
Kovar FM, Thallinger C, Marsik CL, Perkmann T, Puhalla H, Haslacher H,
Wrba F, Wagner OF, Gruenberger T, Endler G.
Wien Klin Wochenschr. 2009;121(19-20):638-43
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F,
Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R,
Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F,
Köhne CH.
Lancet Oncol. 2010 Jan;11(1):38-47. Epub 2009 Nov 26.
Bevacizumab Improves Pathological Response of Colorectal Cancer Liver
Metastases Treated with XELOX/FOLFOX.
Klinger M, Tamandl D, Eipeldauer S, Hacker S, Herberger B, Kaczirek K,
Dorfmeister M, Gruenberger B, Gruenberger T.
Ann Surg Oncol. 2010 Aug;17(8):2059-65. Epub 2010 Feb 23
Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F,
Weber M, Ba-Ssalamah A.
Eur J Radiol. 2010 Apr 12. [Epub ahead of print]
Liver resection remains a safe procedure after neoadjuvant
chemotherapy including bevacizumab: a case-controlled study
Tamandl D, Gruenberger B, Klinger M, Herberger B, Kaczirek K,
Fleischmann E, Gruenberger T
Thrombospondin-1: a unique marker to identify in vitro platelet activation
when monitoring in vivo processes
Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K,
Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M,
Brostjan C
J Thrombosis and Haemostasis 2010 May 12. [Epub ahead of print]
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009 Van Cutsem E, Dicato M, Arber N, Berlin J, Cervantes A, Ciardiello F, De
Gramont A, Diaz-Rubio E, Ducreux M, Geva R, Glimelius B, Jones RG,
Grothey A, Gruenberger T, Haller D, Haustermans K, Labianca R, Lenz
HJ, Minsky B, Nordlinger B, Ohtsu A, Pavlidis N, Rougier P, Schmiegel W,
Van de Velde C, Schmoll HJ, Sobrero A, Tabernero JAnn Oncol. 2010 Jun;21 Suppl 6:vi1-10 Sinusoidal obstruction syndrome impairs long-term outcome of colorectal
liver metastases treated with resection after neoadjuvant chemotherapy
Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K,
Gruenberger B, Gruenberger T
Ann Surg Oncol. 2010 Sep 16. [Epub ahead of print] 88. Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis
Pulitanò C, Bodingbauer M, Aldrighetti L, de Jong M, Parks R, Castillo, F,
Schulick R, Wigmore S, Choti M, Garden J, Gruenberger T, Pawlik T
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable
advanced or metastatic biliary tract cancer: a phase 2 study
Gruenberger B, Schueller J, Heubrandtner U, Wrba F, Tamandl D, Kaczirek
K, Roka R, Freimann-Pircher S, Gruenberger T
Evaluation of chemotherapy-associated liver injury in patients with
colorectal cancer liver metastases using indocyanine green clearance
testing
Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J,
Gruenberger T
Ann Surg Oncol 2010; accepted

Source: http://www.ordination-gruenberger.at/en/files/publications_T_Gruenberger.pdf

July-dec 2012.pmd

Tissue Engineering : Future of Pediatric EndodonticsDr. George Kurian Panampally, MDS*, Dr. Vivek M. Patil, MDS**,Dr. Rehan Khan, MDS***,During the last 10–15 years, there has been a tremendous increase in our clinical “tools” (i.e. materials,instruments and medications) and knowledge from the trauma and tissue engineering fields that can beapplied to regeneration of a functional pulp-de

Applicant must type or clearly print all information

Applicant must type or clearly print all information NAME___________________________________________Date of Birth____________ Last First MI mm/dd/yyyy OLN________________________State______SSN________________Hm Ph #_____________________ Street Address_________________________________City____________Zip_________ Mailing Address_______________________________City____________Zip_________ Commi

Copyright © 2010-2014 Medical Articles